Vandetanib
CAS: 443913-73-3
Molecular Formula: C22H24BrFN4O2
Molecular Weight: 475.35
Product description:A synthesis of aniline quinazoline compounds, for oral small molecule targets more butyric acid kinase inhibitor (TKI), at the same time acting on tumor cells of EGFR and VEGFR and RET tyrosine kinase, still can selectively inhibit other tyrosine kinase, and serine/threonine kinase, multiple targets joint block signaling, therefore is a kind of multi-channel tumor signal transduction inhibitors.
Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
for: Product Quotation ( Product suppliers),COA (Certificate of Analysis), New Sales
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@aushealthingredients.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: